Goldman Sachs analyst Alex Scott downgraded MetLife to Neutral from Buy with a price target of $78, down from $80. The downgrade is driven by the view that life insurance faces a more challenging year in 2023 "as well as some company specific sensitivities to what the environment may present," Scott tells investors in a research note. The analyst sees MetLife having credit exposure to risk-based capital ratios that is above the peer average in a scenario that is similar to 2000-2002 credit losses. Additionally, the company’s real estate exposure and alternative investment portfolio are also both above average, says Scott.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MET:
- MetLife price target raised to $80 from $77 at JPMorgan
- MetLife put volume heavy and directionally bearish
- Ameriprise downgraded to Market Perform from Outperform at Keefe Bruyette
- Prudential downgraded to Underweight from Equal Weight at Wells Fargo
- MetLife Investment Management to acquire Affirmative Investment Management